Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action

Endocrinology

Volumn 138, Issue 12, 1997, Pages 5645-5648

  Mohseni Zadeh, Sarah ^a   Binoux, Michel ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN B; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHINESE HAMSTER; HORMONE RECEPTOR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR AFFINITY;

EID: 0030670080     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.12.5714     Document Type: Article

References (15)

1. Binoux M, Lalou C, Lassarre C, Segovia B 1994 Regulation of IGF bioavailability by IGFBP proteases. In: Baxter RC, Gluckman PD, Rosenfeld RG (ed). The insulin-like growth factors and their regulatory proteins. Elsevier, Amsterdam p 217-226.
2. Lalou C, Lassarre C, Binoux M 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206-3212.
3. Lalou C, Sawamura S, Segovia B, Ogawa Y, Binoux M 1997 Proteolytic fragments of insulin-like growth factor binding protein-3 : N-terminal sequences and relationships between structure and biological activity. CR Acad Sci Paris/Life Sciences 320 :621-628.
4. Mohseni Zadeh S, Binoux M 1997 The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138 :3069-3072.
5. Villaudy J, Delbé J, Blat C, Desauty G, Goldé A, Harel L 1991 An IGF binding protein is an inhibitor of FGF stimulation. J Cell Physiol 149:492-496.
6. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367.
7. Oh Y, Müller HL, Lee D, Fielder PJ, Rosenfeld RG 1993 Characterization of the affinities of Insulin-like Growth Factor (IGF)-Binding Proteins 1-4 for IGF-I, IGF-II, IGF-I/Insulin Hybrid, and IGF-I analogs. Endocrinology 132 :1337-1343.
8. Rechler MM, Nissley SP 1985 The nature and regulation of the receptors for insulin-like growth factors. Ann Rev Physiol 47:425-442.
9. Conover CA 1991 A unique receptor-independent mechanism by which insulin-like growth factor I regulates the availability of insulin-like growth factor binding proteins in normal and transformed human fibroblasls. J Clin Invest 88:1354-1361.
10. DeMeyts P 1994 The structural basis of insulin and insulin-like growth factor-I (IGF-I) receptor binding and negative cooperatively, and its relevance to mitogenic versus metabolic signaling. Diabetologia 37 (suppl 2):S135-S148.
11. Jansson M, Hallén D, Koho H, Andersson G, Berghard L, Heidrich J, Nyberg E, Uhlén M, Kördel J, Nilsson B 1997 Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change. J Biol Chem 272:8189-8197.
12. Christiansen K, Tranum-Jensen J, Carlsen J, Vinten J 1991 A model for the quarternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl Acad Sci USA 88:249-252.
13. Schaefer EM, Erickson HP, Federwisch M, Wollmer A, Ellis L 1992 Structural organization of the human insulin receptor ectodomain. J Biol Chem 267:23393-23402.
14. Fowlkes JL, Serra DM 1996 Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor binding protein-3. J Biol Chem 271:14676-14679.
15. Oh Y, Müller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048.